CureVac
is a Germany-based biopharmaceutical company that researches and develops mRNA therapies for the treatment of cancer and infectious diseases... Read moreCureVac
is a Germany-based biopharmaceutical company that researches and develops mRNA therapies for the treatment of cancer and infectious diseases... Read more
News
Apr 27, 2026
European Biotechnology
CureVac: CureVac takes Moderna to court over mRNA vaccine patents
Dec 18, 2025
FinanzNachrichten
CureVac: BioNTech SE: BioNTech Closes Acquisition of CureVac N.V. Including Subsequent Offering Period to Strengthen its Unique Position in the mRNA Field
Dec 06, 2025
Yahoo
CureVac: CureVac Valuation After 2025 Rebound and DCF Suggests Large Gap to Fair Value
Dec 03, 2025
FinanzNachrichten
CureVac: BioNTech SE: BioNTech Achieves Minimum Condition in CureVac Exchange Offer
Nov 28, 2025
Seeking Alpha
CureVac: CureVac N.V. (CVAC) Shareholder/Analyst Call Prepared Remarks Transcript
Nov 24, 2025
FinanzNachrichten
CureVac: CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2025 and Provides Business Updates
Nov 24, 2025
Yahoo
CureVac: Update: CureVac Q3 Earnings, Revenue Fall; German Regulators Clear BioNTech Acquisition
Nov 17, 2025
Yahoo
CureVac: CureVac (NasdaqGM:CVAC): Exploring Valuation After Strong Share Price Gains in 2024
Oct 01, 2025
Seeking Alpha
CureVac: CureVac: The Hidden Value Of The mRNA Wallet
Aug 11, 2025
Pharmabiz
CureVac: BioNTech reaches agreement to get a nonexclusive license for mRNAbased Covid19 and/or influenza products and resolve patent litigation with CureVac & GSK
CureVac Competitors
1
2
3
4
5
6
7
8
9
10